Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
MOTS-c structure

MOTS-c

Other
Phase 1 Research
25%
Moderate Risk
3/5

Warnings

Extremely unstable peptide
No human clinical trials completed
WADA prohibited

Contraindications

PregnancyBreastfeedingDiabetes Medication Use

Drug Interactions

MetforminDiabetes Medications

Possible Side Effects

HypoglycemiaInjection Site Reactions

Legal & Regulatory

FDA Status Research Only
WADA Status Prohibited in Sport
Prescription Not Required

Pregnancy

Category X - Contraindicated